Recursion Pharmaceuticals, Inc.
RXRX
$3.05
-$0.10-3.18%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 654.47M | 743.29M | 659.84M | 525.11M | 500.45M |
| Total Receivables | 13.59M | 24.65M | 21.91M | 21.61M | 46.12M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 11.74M | 11.74M | -- | -- | 2.47M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 29.76M | 33.16M | 32.36M | 40.44M | 35.10M |
| Total Current Assets | 709.56M | 812.85M | 714.11M | 587.16M | 584.15M |
|
|
|||||
| Total Current Assets | 709.56M | 812.85M | 714.11M | 587.16M | 584.15M |
| Net Property, Plant & Equipment | 157.32M | 169.48M | 181.24M | 193.60M | 204.78M |
| Long-term Investments | 160.17M | 162.16M | 162.04M | 164.27M | 158.11M |
| Goodwill | 160.17M | 162.16M | 162.04M | 164.27M | 158.11M |
| Total Other Intangibles | 294.07M | 309.90M | 322.34M | 341.32M | 335.79M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 14.00M | 15.34M | 15.39M | 11.60M | 18.01M |
| Total Assets | 1.34B | 1.47B | 1.40B | 1.30B | 1.31B |
|
|
|||||
| Total Accounts Payable | 20.35M | 18.12M | 13.94M | 19.31M | 25.09M |
| Total Accrued Expenses | 53.20M | 69.53M | 72.15M | 83.00M | 55.18M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 22.35M | 21.75M | 20.44M | 20.48M | 20.44M |
| Total Finance Division Other Current Liabilities | 33.80M | 38.31M | 48.57M | 41.23M | 41.28M |
| Total Other Current Liabilities | 33.80M | 38.31M | 48.57M | 41.23M | 41.28M |
| Total Current Liabilities | 129.70M | 147.71M | 155.10M | 164.03M | 141.98M |
|
|
|||||
| Total Current Liabilities | 129.70M | 147.71M | 155.10M | 164.03M | 141.98M |
| Long-Term Debt | 7.18M | 193.00K | 11.90M | 14.20M | 16.45M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 42.84M | 56.02M | 50.03M | 53.40M | 56.02M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 135.03M | 139.35M | 135.55M | 151.59M | 156.84M |
| Total Liabilities | 314.75M | 343.27M | 352.58M | 383.21M | 371.29M |
|
|
|||||
| Common Stock & APIC | 3.19B | 3.17B | 2.98B | 2.68B | 2.55B |
| Retained Earnings | -2.19B | -2.08B | -1.97B | -1.81B | -1.63B |
| Treasury Stock & Other | 26.66M | 36.72M | 34.09M | 43.62M | 14.15M |
| Total Common Equity | 1.02B | 1.13B | 1.05B | 919.15M | 933.95M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.02B | 1.13B | 1.05B | 919.15M | 933.95M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.02B | 1.13B | 1.05B | 919.15M | 933.95M |
|
|
|||||